New G protein inhibitor identified, with potential for cancer therapies
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells
RI-MUHC success in grant competition for transplantation research
Researchers awarded funds from the Canadian Donation and Transplantation Research Program for...
RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
RI-MUHC trainee wins award at Canadian Society of Nephrology meeting
Congratulations to Tho-Alfakar Al-Aubodah!
How does the hunger-suppressing hormone leptin cross the blood-brain barrier?
Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC
New research looks at vaccination efficacy and hemodialysis
Dialysis patients do not develop adequate antibodies with one dose of SARS-CoV-2 vaccine
FALL 2020 CIHR COMPETITION RESULTS
RI-MUHC teams received $6.9 million in project funding and $2 million more for COVID-19 research
Understanding the health impact of inactivity for the benefit of older adults and astronauts
A study using bedrest as an analog to microgravity will provide data for eight Canadian research projects
INESSS honours McGill team for contributions to pandemic hospital projections
Public health researchers David Buckeridge and Mathieu Maheu-Giroux lead valuable support initiative
Suzanne Morin named to CIHR Institute Advisory Board
RI-MUHC researcher promotes musculoskeletal health for Canadians